Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-03
1997-12-09
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514323, 514563, 514620, 514626, A61K 31405, A61K 31445
Patent
active
056961472
ABSTRACT:
Synthetic mammalian matrix metalloprotease inhibitors are useful in controlling angiogenesis. These compounds are thus useful in controlling the growth of tumors and in controlling neovascular glaucomas.
REFERENCES:
patent: 4291048 (1981-09-01), Gold
patent: 4558034 (1985-12-01), Galardy et al.
patent: 4599361 (1986-07-01), Dickens et al.
patent: 4681894 (1987-07-01), Murray et al.
patent: 4698342 (1987-10-01), Crosby
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4918105 (1990-04-01), Cartwright et al.
patent: 4943587 (1990-07-01), Cetenko et al.
patent: 4996358 (1991-02-01), Handa et al.
patent: 5183900 (1993-02-01), Galardy et al.
patent: 5189178 (1993-02-01), Galardy et al.
patent: 5239078 (1993-08-01), Galardy et al.
patent: 5304604 (1994-04-01), Davidson et al.
patent: 5453438 (1995-09-01), Campion et al.
Dialog.TM. Computer Database Abstract of International (PCT) Patent No. WO 91/11193 (Jan. 25, 1991).
Dialog.TM. Computer Database Abstract of European Patent Application No. 0424193 (Apr. 24, 1991).
Mullins et al., "The role of proteinases in cellular invasiveness" Biochem. Biophys. Acta (1983) 695:177-214.
Reich et al., "Effects of inhibitors of plasminogen activator, serine proteinases, and collagenases IV on the invasion of basement membranes by metastatic cells" (1988) Cancer Res. (1988) 48:3307-3312.
Nishino et al., "Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatography" Biochemistry (1979) 18:4340-4347.
Nishino et al., "Peptide hydroxamic acids an inhibitors of thermolysin" Biochemistry (1978) 17:2846-2850.
G. S. Schultz et al., "Treatment of Alkali-Injured Corneas With a Synthetic Inhibitor of Matrix Metalloprotease" Investigative Ophthalmology & Visual Science, vol. 33, No. 12, pp. 3325-3331, Nov. 1992.
Glycomed, Inc.
McKane Joseph
LandOfFree
Inhibition of angiogenesis by synthetic matrix metalloprotease i does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of angiogenesis by synthetic matrix metalloprotease i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis by synthetic matrix metalloprotease i will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1608106